{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T03:30:37Z","timestamp":1768534237762,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-02097-y","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T16:56:00Z","timestamp":1764867360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prediction of hepatic functional reserve using a gadoxetic acid\u2013enhanced MRI\u2013derived \u2018Severity Index\u2019"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-6794","authenticated-orcid":false,"given":"Fatih","family":"I\u015f\u0131k","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"Yal\u00e7\u0131n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammed Furkan","family":"Barutcigil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Tugrul","family":"Akkus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adem","family":"Karaman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00fcrkan","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatih","family":"Alper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"key":"2097_CR1","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","volume":"70","author":"SK Asrani","year":"2019","unstructured":"Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. J Hepatol. 2019;70:151\u201371. https:\/\/doi.org\/10.1016\/j.jhep.2018.09.014.","journal-title":"J Hepatol"},{"key":"2097_CR2","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217\u201331. https:\/\/doi.org\/10.1016\/j.jhep.2005.10.013.","journal-title":"J Hepatol"},{"key":"2097_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1111\/j.1478-3231.2012.02830.x","volume":"32","author":"A Zipprich","year":"2012","unstructured":"Zipprich A, Garcia-Tsao G, Rogowski S, Fleig WE, Seufferlein T, Dollinger MM. Prognostic indicators of survival in patients with compensated and decompensated cirrhosis. Liver Int. 2012;32:1407\u201314. https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02830.x.","journal-title":"Liver Int"},{"key":"2097_CR4","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RNH Pugh","year":"1973","unstructured":"Pugh RNH, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. J Br Surg. 1973;60:646\u20139. https:\/\/doi.org\/10.1002\/bjs.1800600817.","journal-title":"J Br Surg"},{"key":"2097_CR5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1053\/jhep.2001.22172","volume":"33","author":"PS Kamath","year":"2001","unstructured":"Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with End\u2013Stage liver disease. Hepatology. 2001;33:464\u201370. https:\/\/doi.org\/10.1053\/jhep.2001.22172.","journal-title":"Hepatology"},{"key":"2097_CR6","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson PJ, Berhane S, Kagebayashi C, Satomura S, Teng M, Reeves HL, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach\u2014the ALBI grade. J Clin Oncol. 2015;33:550\u20138. https:\/\/doi.org\/10.1200\/JCO.2014.57.9151.","journal-title":"J Clin Oncol"},{"key":"2097_CR7","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, Sola R, Correa MC, Montaner J, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection\u2020\u2021. Hepatology. 2006;43:1317\u201325. https:\/\/doi.org\/10.1002\/hep.21178.","journal-title":"Hepatology"},{"key":"2097_CR8","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","volume":"130","author":"SW Biggins","year":"2006","unstructured":"Biggins SW, Kim WR, Terrault NA, Saab S, Balan V, Schiano T, et al. Evidence-based incorporation of serum sodium concentration into MELD. Gastroenterology. 2006;130:1652\u201360. https:\/\/doi.org\/10.1053\/j.gastro.2006.02.010.","journal-title":"Gastroenterology"},{"key":"2097_CR9","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1016\/S0140-6736(14)60121-5","volume":"383","author":"EA Tsochatzis","year":"2014","unstructured":"Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383:1749\u201361. https:\/\/doi.org\/10.1016\/S0140-6736(14)60121-5.","journal-title":"Lancet"},{"key":"2097_CR10","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","volume":"75","author":"A Berzigotti","year":"2021","unstructured":"Berzigotti A, Tsochatzis E, Boursier J, Castera L, Cazzagon N, Friedrich-Rust M, et al. EASL clinical practice guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update. J Hepatol. 2021;75:659\u201389. https:\/\/doi.org\/10.1016\/j.jhep.2021.05.025.","journal-title":"J Hepatol"},{"key":"2097_CR11","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.jhep.2012.01.031","volume":"57","author":"BE Van Beers","year":"2012","unstructured":"Van Beers BE, Pastor CM, Hussain HK, Primovist. Eovist: what to expect? J Hepatol. 2012;57:421\u20139. https:\/\/doi.org\/10.1016\/j.jhep.2012.01.031.","journal-title":"J Hepatol"},{"key":"2097_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0022-3565(24)34879-7","volume":"290","author":"JE van Montfoort","year":"1999","unstructured":"van Montfoort JE, Stieger B, Meijer DK, Weinmann HJ, Meier PJ, Fattinger KE. Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1. J Pharmacol Exp Ther. 1999;290:153\u20137.","journal-title":"J Pharmacol Exp Ther"},{"key":"2097_CR13","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1006\/bbrc.1999.0454","volume":"257","author":"L Pascolo","year":"1999","unstructured":"Pascolo L, Cupelli F, Anelli PL, Lorusso V, Visigalli M, Uggeri F, et al. Molecular mechanisms for the hepatic uptake of magnetic resonance imaging contrast agents. Biochem Biophys Res Commun. 1999;257:746\u201352. https:\/\/doi.org\/10.1006\/bbrc.1999.0454.","journal-title":"Biochem Biophys Res Commun"},{"key":"2097_CR14","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1016\/S1076-6332(96)80544-7","volume":"3","author":"H-J Weinmann","year":"1996","unstructured":"Weinmann H-J, Bauer H, Frenzel T, M\u00fchler A, Ebert W. Mechanism of hepatic uptake of gadoxetate disodium. Acad Radiol. 1996;3:S232\u20134. https:\/\/doi.org\/10.1016\/S1076-6332(96)80544-7.","journal-title":"Acad Radiol"},{"key":"2097_CR15","doi-asserted-by":"publisher","unstructured":"Haimerl M, Verloh N, Zeman F, Fellner C, Nickel D, Lang SA, et al. Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: comparison between signal-intensity-based indices and T1 relaxometry. Sci Rep Nat Publishing Group. 2017;7. https:\/\/doi.org\/10.1038\/srep43347.","DOI":"10.1038\/srep43347"},{"key":"2097_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/RLI.0b013e318200f67d","volume":"46","author":"T Katsube","year":"2011","unstructured":"Katsube T, Okada M, Kumano S, Hori M, Imaoka I, Ishii K, et al. Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol. 2011;46:277\u201383. https:\/\/doi.org\/10.1097\/RLI.0b013e318200f67d.","journal-title":"Invest Radiol"},{"key":"2097_CR17","doi-asserted-by":"publisher","first-page":"15408","DOI":"10.1038\/srep15408","volume":"5","author":"N Verloh","year":"2015","unstructured":"Verloh N, Utpatel K, Haimerl M, Zeman F, Fellner C, Fichtner-Feigl S, et al. Liver fibrosis and Gd-EOB-DTPA-enhanced MRI: a histopathologic correlation. Sci Rep. 2015;5:15408. https:\/\/doi.org\/10.1038\/srep15408.","journal-title":"Sci Rep"},{"key":"2097_CR18","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00330-014-3108-y","volume":"24","author":"N Verloh","year":"2014","unstructured":"Verloh N, Haimerl M, Zeman F, Schlabeck M, Barreiros A, Loss M, et al. Assessing liver function by liver enhancement during the hepatobiliary phase with Gd-EOB-DTPA-enhanced MRI at 3 tesla. Eur Radiol. 2014;24:1013\u20139. https:\/\/doi.org\/10.1007\/s00330-014-3108-y.","journal-title":"Eur Radiol"},{"key":"2097_CR19","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1148\/radiol.2019190734","volume":"294","author":"N Bastati","year":"2020","unstructured":"Bastati N, Beer L, Mandorfer M, Poetter-Lang S, Tamandl D, Bican Y, et al. Does the functional liver imaging score derived from gadoxetic acid\u2013enhanced MRI predict outcomes in chronic liver disease? Radiology. 2020;294:98\u2013107. https:\/\/doi.org\/10.1148\/radiol.2019190734.","journal-title":"Radiology"},{"key":"2097_CR20","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/jmri.21956","volume":"30","author":"U Motosugi","year":"2009","unstructured":"Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Kitamura T, et al. Liver parenchymal enhancement of hepatocyte-phase images in Gd-EOB-DTPA-enhanced MR imaging: which biological markers of the liver function affect the enhancement? J Magn Reson Imaging. 2009;30:1042\u20136. https:\/\/doi.org\/10.1002\/jmri.21956.","journal-title":"J Magn Reson Imaging"},{"key":"2097_CR21","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00330-004-2236-1","volume":"14","author":"P Reimer","year":"2004","unstructured":"Reimer P, Schneider G, Schima W. Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol. 2004;14:559\u201378. https:\/\/doi.org\/10.1007\/s00330-004-2236-1.","journal-title":"Eur Radiol"},{"key":"2097_CR22","doi-asserted-by":"publisher","first-page":"e311","DOI":"10.1016\/j.ejrad.2011.01.020","volume":"80","author":"T Tamada","year":"2011","unstructured":"Tamada T, Ito K, Higaki A, Yoshida K, Kanki A, Sato T, et al. Gd-EOB-DTPA-enhanced MR imaging: evaluation of hepatic enhancement effects in normal and cirrhotic livers. Eur J Radiol. 2011;80:e311\u20136. https:\/\/doi.org\/10.1016\/j.ejrad.2011.01.020.","journal-title":"Eur J Radiol"},{"key":"2097_CR23","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1007\/s00330-024-10590-1","volume":"34","author":"S Poetter-Lang","year":"2024","unstructured":"Poetter-Lang S, Ambros R, Messner A, Kristic A, Hodge JC, Bastati N, et al. Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on Gadoxetic acid\u2013enhanced MRI? A large-cohort study. Eur Radiol. 2024;34:5215\u201327. https:\/\/doi.org\/10.1007\/s00330-024-10590-1.","journal-title":"Eur Radiol"},{"key":"2097_CR24","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1038\/s41598-018-37689-y","volume":"9","author":"JD Stief","year":"2019","unstructured":"Stief JD, Haase M, L\u00fcdemann L, Theilig D, Schmelzle M, Hamm B, et al. Combined morphological and functional liver MRI using spin-lattice relaxation in the rotating frame (T1\u03c1) in conjunction with Gadoxetic Acid-enhanced MRI. Sci Rep. 2019;9:2083. https:\/\/doi.org\/10.1038\/s41598-018-37689-y.","journal-title":"Sci Rep"},{"key":"2097_CR25","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.cgh.2009.05.033","volume":"7","author":"AG Shah","year":"2009","unstructured":"Shah AG, Lydecker A, Murray K, Tetri BN, Contos MJ, Sanyal AJ. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104\u201312. https:\/\/doi.org\/10.1016\/j.cgh.2009.05.033.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2097_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1148\/radiol.11100586","volume":"260","author":"A Yamada","year":"2011","unstructured":"Yamada A, Hara T, Li F, Fujinaga Y, Ueda K, Kadoya M, et al. Quantitative evaluation of liver function with use of gadoxetate disodium\u2013enhanced MR imaging. Radiology. 2011;260:727\u201333. https:\/\/doi.org\/10.1148\/radiol.11100586.","journal-title":"Radiology"},{"key":"2097_CR27","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1111\/jgh.13250","volume":"31","author":"A Hiraoka","year":"2016","unstructured":"Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, et al. Usefulness of albumin\u2013bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma. J Gastroenterol Hepatol. 2016;31:1031\u20136. https:\/\/doi.org\/10.1111\/jgh.13250.","journal-title":"J Gastroenterol Hepatol"},{"key":"2097_CR28","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1007\/s00261-023-04176-6","volume":"49","author":"J Hu","year":"2024","unstructured":"Hu J, Wang X, Prince M, Wang F, Sun J, Yang X, et al. Gd-EOB-DTPA enhanced MRI based radiomics combined with clinical variables in stratifying hepatic functional reserve in HBV infected patients. Abdom Radiol. 2024;49:1051\u201362. https:\/\/doi.org\/10.1007\/s00261-023-04176-6.","journal-title":"Abdom Radiol"},{"key":"2097_CR29","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.3748\/wjg.v26.i11.1208","volume":"26","author":"W-S Zhu","year":"2020","unstructured":"Zhu W-S, Shi S-Y, Yang Z-H, Song C, Shen J. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure. World J Gastroenterol. 2020;26:1208\u201320. https:\/\/doi.org\/10.3748\/wjg.v26.i11.1208.","journal-title":"World J Gastroenterol"},{"key":"2097_CR30","doi-asserted-by":"publisher","first-page":"277","DOI":"10.3390\/jimaging8100277","volume":"8","author":"J Sack","year":"2022","unstructured":"Sack J, Nitsch J, Meine H, Kikinis R, Halle M, Rutherford A. Quantitative analysis of liver disease using MRI-Based radiomic features of the liver and spleen. J Imaging. 2022;8:277. https:\/\/doi.org\/10.3390\/jimaging8100277.","journal-title":"J Imaging"},{"key":"2097_CR31","doi-asserted-by":"publisher","first-page":"e85658","DOI":"10.1371\/journal.pone.0085658","volume":"8","author":"M Haimerl","year":"2013","unstructured":"Haimerl M, Verloh N, Zeman F, Fellner C, M\u00fcller-Wille R, Schreyer AG, et al. Assessment of clinical signs of liver cirrhosis using T1 mapping on Gd-EOB-DTPA-enhanced 3T MRI. PLoS ONE. 2013;8:e85658. https:\/\/doi.org\/10.1371\/journal.pone.0085658.","journal-title":"PLoS ONE"},{"key":"2097_CR32","doi-asserted-by":"publisher","first-page":"20120653","DOI":"10.1259\/bjr.20120653","volume":"86","author":"H Nilsson","year":"2013","unstructured":"Nilsson H, Blomqvist L, Douglas L, Nordell A, Janczewska I, N\u00e4slund E, et al. Gd-EOB-DTPA-enhanced MRI for the assessment of liver function and volume in liver cirrhosis. Br J Radiol. 2013;86:20120653. https:\/\/doi.org\/10.1259\/bjr.20120653.","journal-title":"Br J Radiol"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02097-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-02097-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-02097-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:25:35Z","timestamp":1768472735000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12880-025-02097-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2097"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-02097-y","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"23 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective, observational study was approved by the Atat\u00fcrk University Faculty of Medicine Clinical Research Ethics Committee (Erzurum, T\u00fcrkiye; Approval No. B.30.2.ATA.0.01.00\/405). In view of the retrospective design and the use of existing, anonymized clinical data and images, the Committee waived the requirement for written informed consent in accordance with institutional policy and national regulations. All procedures were performed in accordance with the ethical standards of the institutional and\/or national research committee and with the Declaration of Helsinki (1975, as revised in 2013). No patient-identifiable data were collected or reported.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}